Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

Advancing two pivotal Phase 3 trials of BXCL501 for acute treatment of agitation associated with bipolar disorders, schizophrenia, and ...

A psychiatrist, Dr Yennusom Maalug, has cautioned that, untreated bipolar or mood disorders could lead to serious mental and ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

BioXcel Therapeutics (BTAI) announced the achievement of clinical and regulatory progress for its pivotal Phase 3 clinical trials of BXCL501 for the acute treatment of agitation associated with ...

Although bipolar disorder is a chronic mental health condition, treatments are available to help manage it. This includes medication, psychotherapy, and lifestyle strategies. Bipolar disorder is a ...

WEST JORDAN, Utah — A suspect was taken to the hospital after a police response escalated to a shooting early Sunday morning.

Intra-Cellular Therapies' lumateperone shows significant efficacy in reducing schizophrenia relapse rates, with a 63% risk ...